130 related articles for article (PubMed ID: 7763030)
1. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemistry of biomolecular markers of lung cancer].
Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC
Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
[TBL] [Abstract][Full Text] [Related]
5. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
6. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas.
Jiang SX; Sato Y; Kuwao S; Kameya T
J Pathol; 1995 Oct; 177(2):135-8. PubMed ID: 7490679
[TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2 in small cell lung carcinoma cells.
Ikegaki N; Katsumata M; Minna J; Tsujimoto Y
Cancer Res; 1994 Jan; 54(1):6-8. PubMed ID: 8261463
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
[TBL] [Abstract][Full Text] [Related]
10. Pathology of non-small cell lung cancer. New diagnostic approaches.
Linnoila I
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774
[TBL] [Abstract][Full Text] [Related]
11. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
[TBL] [Abstract][Full Text] [Related]
12. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
[TBL] [Abstract][Full Text] [Related]
16. The preliminary estimation of bcl-2, bcl-X(L) and p53 genes expression in locally advanced non-small cell lung cancer.
Karczmarek-Borowska B; Filip A; Zdunek M; Korobowicz E; Wojcierowski J; Korszeń-Pilecka I; Furmanik F
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):124-31. PubMed ID: 15314971
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
[TBL] [Abstract][Full Text] [Related]
18. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
[TBL] [Abstract][Full Text] [Related]
19. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Tumour Biol; 1996; 17(6):341-4. PubMed ID: 8938949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
